☆ 4.6 Article

Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Antibody-induced procoagulant platelets in severe COVID-19 infection

Karina Althaus et al.

Summary: The pathophysiology of COVID-19-associated thrombosis is multifactorial, involving procoagulant platelets and alterations in various cellular processes. Studies have found that COVID-19 patients exhibit increased platelet dysfunction and apoptosis markers, suggesting a potential role of antibody-mediated procoagulant platelets in contributing to sustained thromboembolic risk in ICU COVID-19 patients.

BLOOD (2021)

添加到收藏夹

Article Immunology

Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients

Ana Marcos-Jimenez et al.

Summary: The immune response in peripheral blood of COVID-19 patients is associated with disease severity, with an imbalanced humoral response potentially being a characteristic of severe cases.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Letter Hematology

Platelets are Hyperactivated but Show Reduced Glycoprotein VI Reactivity in COVID-19 Patients

Valentine Leopold et al.

THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Cell Biology

SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype

Dario Bongiovanni et al.

Summary: This study found that platelets of COVID-19 patients showed increased expression of activation markers without stimulation, and further elevated expression of P-selectin when stimulated with TRAP. However, COVID-19 platelets exhibited reduced capacity to express LAMP-3 and P-selectin upon TRAP stimulation. These findings suggest a hyperactivated platelet phenotype during SARS-CoV-2 infection, potentially contributing to the observed hypercoagulopathy in COVID-19 patients.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Hematology

Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia

Ishac Nazy et al.

Summary: Our study excludes heparin-induced thrombocytopenia in critically ill COVID-19 patients and identifies platelet-activating immune complexes as a novel mechanism contributing to the disease.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Hematology

Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19

Stefanie Hammer et al.

Summary: This study found that COVID-19 patients have impaired fibrinolytic activity in the blood. Compared with healthy controls, significant abnormalities in clotting and fibrinolysis markers were observed in ICU COVID-19 patients.

THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1

Mingming Han et al.

Summary: This study demonstrates that the spike protein of SARS-CoV-2 virus can stimulate human pulmonary microvascular endothelial cells to produce PAI-1, leading to endothelial dysfunction. The research found that protein degradation and factors such as aging and metabolic disorders play a role in the impact of virus infection.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

添加到收藏夹

Article Oncology

SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism

Shu Shen et al.

Summary: Evidence suggests that SARS-CoV-2 interacts with platelets and megakaryocytes via an ACE2-independent mechanism, potentially regulating expression of alternative receptors associated with COVID-19 coagulation dysfunction.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Hematology

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study

Ganeem K. Juneja et al.

Summary: Immunothrombosis and coagulopathy in the lung microvasculature may lead to lung injury and disease progression in COVID-19. Biomarkers such as elevated D-dimer were associated with disease severity, while clot lysis time, sTM, PAI-1, and plasminogen levels may have predictive ability for mortality.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5

Huriye Ercan et al.

Summary: Platelets in COVID-19 patients show significant changes in activation phenotype, processing of coagulation factor F13A1, and phospholipid-binding protein ANXA5 compared to healthy individuals. These alterations in platelets are strongly associated with fatal outcomes during COVID-19 infection.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Platelet Reactivity and Coagulation Markers in Patients with COVID-19

Adriadne J. Bertolin et al.

Summary: In this study, platelet reactivity was significantly lower in patients with non-severe COVID-19 compared to healthy controls, despite higher levels of d-dimer, fibrinogen, and plasminogen activator inhibitor 1 (PAI-1) in the COVID-19 group. Thromboelastometry also indicated a hypercoagulable state in the COVID-19 group.

ADVANCES IN THERAPY (2021)

添加到收藏夹

Letter Hematology

Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts

Conor McCafferty et al.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Initiates Programmed Cell Death in Platelets

Milka Koupenova et al.

Summary: The study revealed that platelets in COVID-19 patients contain viral RNA and proteins, and that SARS-CoV-2 can directly influence platelet internalization and cell death, which may contribute to complications like thrombosis.

CIRCULATION RESEARCH (2021)

添加到收藏夹

Article Hematology

Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection

Sandra Lopez-Castaneda et al.

Summary: In hospitalized COVID-19 patients, alterations in inflammatory and coagulation biomarkers are closely related to poor prognosis, with significantly elevated levels of D-dimer and PAI-1 in severe cases, along with distinct differences in inflammatory markers between non-severe patients and those who succumbed to the disease.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Platelet-leukocyte interplay during vascular disease

Waltraud C. Schrottmaier et al.

ATHEROSCLEROSIS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China Prevalence, Risk Factors, and Outcome

Li Zhang et al.

CIRCULATION (2020)

添加到收藏夹

Article Hematology

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy

Leo Nicolai et al.

CIRCULATION (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease

Tessa J. Barrett et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Article Medical Laboratory Technology

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Giuseppe Lippi et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Article Hematology

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Hanny Al-Samkari et al.

BLOOD (2020)

添加到收藏夹

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

BLOOD (2020)

添加到收藏夹

Article Hematology

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

Danying Liao et al.

LANCET HAEMATOLOGY (2020)

添加到收藏夹

Article Hematology

Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia

Francesco Taus et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

添加到收藏夹

Article Hematology

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19

Eugenio D. Hottz et al.

BLOOD (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques

Malika Aid et al.

CELL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

Younes Zaid et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Article Hematology

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

F. A. Klok et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Hematology

Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels

P. Demelo-Rodriguez et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Hematology

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Corrado Lodigiani et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Oncology

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

Si Zhang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome

Sujin Kang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Review Peripheral Vascular Disease

Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System Pressing Needs and Best Research Practices

Matthew A. Sparks et al.

HYPERTENSION (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

Yu Chen et al.

MOLECULAR MEDICINE (2020)

添加到收藏夹

Review Critical Care Medicine

The unique characteristics of COVID-19 coagulopathy

Toshiaki Iba et al.

CRITICAL CARE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals

Emersom C. Mesquita et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Optimized plasma preparation is essential to monitor platelet-stored molecules in humans

Marion Mussbacher et al.

PLOS ONE (2017)

添加到收藏夹

Review Hematology

Platelet Interaction with Innate Immune Cells

Julia Barbara Kral et al.

TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)

添加到收藏夹

Article Hematology

Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes

Waltraud C. Schrottmaier et al.

THROMBOSIS AND HAEMOSTASIS (2015)

添加到收藏夹

Article Clinical Neurology

Plasminogen Activator Inhibitor-1 and Thrombotic Cerebrovascular Diseases

Anna Tjarnlund-Wolf et al.

STROKE (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.